Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

Jeff Sharman, MD, on the outcomes of CAPTIVATE study investigating ibrutinib and venetoclax

Dr. Sharman, Director of Research, Willamette Valley Cancer Institute, Medical Director of Hematology Research, The US Oncology Network, on the outcomes of the CAPTIVATE study investigating ibrutinib and venetoclax in the treatment of front line Chronic Lymphocytic Leukemia (CLL)

Published: 06 December 2018

Recent Videos

video

Nevena Damjanov, MD, shares thoughts on the role of systemic therapy in HCC

Dr. Damjanov, Chief of GI Oncology, Abramson Cancer Center at Penn Presbyterian, University of Pennsylvania, considers whether systemic therapy still ...

video

Jeffrey A. Meyerhardt, MD, on genetic testing in newly diagnosed mCRC

Dr. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute, shares thoughts on genetic testing ...

video

Howard Hochster, MD, on how checkpoint inhibitors are impacting treatment algorithms in mCRC

Dr. Hochster, Associate Director for Clinical Research, Rutgers Cancer Institute of New Jersey, Director of Oncology Research, RWJBarnabas Health, explains ...

video

Jeffrey A. Meyerhardt, MD, shares thoughts on checkpoint inhibitors in adjuvant CRC

Dr. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute offers opinion on whether checkpoint ...

video

Howard Hochster, MD, considers next generation sequencing and mCRC treatment decisions

Dr. Hochster, Associate Director for Clinical Research, Rutgers Cancer Institute of New Jersey, Director of Oncology Research, RWJBarnabas Health, considers ...

video

Jeffrey A. Meyerhardt, MD, on managing 2nd and 3rd line mCRC patients

Dr. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute, tells us how he manages ...

video

Howard Hochster, MD, on the management of mCRC patients receiving regorafenib

Dr. Hochster, Associate Director for Clinical Research, Rutgers Cancer Institute of New Jersey, Director of Oncology Research, RWJBarnabas Health, discusses ...

video

Jeffrey A. Meyerhardt, MD, on whether regorafenib is becoming more tolerable for mCRC patients

Dr. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute, considers whether the results of ...

video

Howard Hochster, MD, explains how to manage 2nd and 3rd line mCRC patients

Dr. Hochster, Associate Director for Clinical Research, Rutgers Cancer Institute of New Jersey, Director of Oncology Research, RWJBarnabas Health, describes ...

video

Jeffrey A. Meyerhardt, MD, considers the BEACON study in BRAF mutated metastatic colorectal cancer

Dr. Meyerhardt, Professor, Medicine, Harvard Medical School, Active Medical Staff, Medical Oncology, Dana-Farber Cancer Institute, discusses the BEACON study investigating ...

Related Videos

video-image

Jeffrey A. Meyerhardt, MD, on whether regorafenib is becoming more tolerable for mCRC patients

video-image

Howard Hochster, MD, on the management of mCRC patients receiving regorafenib

video-image

Jeffrey A. Meyerhardt, MD, on managing 2nd and 3rd line mCRC patients

video-image

Howard Hochster, MD, considers next generation sequencing and mCRC treatment decisions

video-image

Jeffrey A. Meyerhardt, MD, shares thoughts on checkpoint inhibitors in adjuvant CRC

video-image

Howard Hochster, MD, on how checkpoint inhibitors are impacting treatment algorithms in mCRC

video-image

Jeffrey A. Meyerhardt, MD, on genetic testing in newly diagnosed mCRC

video-image

Nevena Damjanov, MD, shares thoughts on the role of systemic therapy in HCC

video-image

Jeffrey A. Meyerhardt, MD, considers the BEACON study in BRAF mutated metastatic colorectal cancer

video-image

Howard Hochster, MD, explains how to manage 2nd and 3rd line mCRC patients

video-image

Howard Hochster, MD, regarding the role of genetic testing in mCRC

video-image

Jasmine Zain, MD, elaborates on the investigation of novel induction regimens in PTCL

video-image

Jasmine Zain, MD, defines successful induction regimens when treating PTCL

video-image

Yana Pikman, MD, on the efforts of the LEAP Consortium in pediatric acute leukemia

video-image

Jasmine Zain, MD, considers the impact of the new induction regimen in PTCL

video-image

Jasmine Zain, MD, discusses novel treatment research regarding transplants at City of Hope

video-image

Yana Pikman, MD, regarding research outcomes from the LEAP Consortium

video-image

Jasmine Zain, MD, on the most exciting studies in lymphoma presented at ASH 2018

video-image

Jasmine Zain, MD, regarding the standard of care in treatment of PTCL

video-image

Rena Feinman, PhD, considers the the role of the microbiome in cancer & response to therapy